<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30">
 <label>30.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Jakaria</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Haque</surname>
    <given-names>M.E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kim</surname>
    <given-names>J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cho</surname>
    <given-names>D.-Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kim</surname>
    <given-names>I.-S.</given-names>
   </name> and 
   <name name-style="western">
    <surname>Choi</surname>
    <given-names>D-K.</given-names>
   </name>
  </person-group> (
  <year>2018</year>) 
  <article-title>Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study</article-title>. 
  <source>Oncotarget</source>
  <volume>9</volume>, 
  <fpage>33601</fpage>â€“
  <lpage>33620</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.26035</pub-id>
  <?supplied-pmid 30323902?>
  <pub-id pub-id-type="pmid">30323902</pub-id>
 </mixed-citation>
</ref>
